Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-090470

Chief Patient Supply Officer sold 4,823 shares at $9.25 ($44,613)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Lunger John Chief Patient Supply Officer 2020-08-03 Sale −4,823 $9.25 $44,613 8,066 D: show line 1 in the form
Open-market sales · 4,823 sh · avg $9.25 · $44,613
Loading xslF345X03/a4.xml…